SCHEMBL10127002

SCHEMBL10127002

Cc1ccc([N+](=O)[O-])c(SC(C)C)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
CYP3A4 P08684 1/20 0.56
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
KAT2B Q92831 1/20 0.39
GPR35 Q9HC97 1/20 0.39
MAPT P10636 3/20 0.38
IDO1 P14902 1/20 0.38
ACHE P22303 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PDE7A Q13946 1/20 0.38
POLB P06746 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282648 0.90 TSHR (0.56) TSHRCYP3A4ALDH1A1KMT2AMEN1
SCHEMBL20150186 0.82 TSHR (0.64) TSHRCYP3A4ALDH1A1KMT2AMEN1
SCHEMBL2061399 0.81 ATM (0.58) TSHRCYP3A4ALDH1A1KMT2AMAPT
SCHEMBL1491752 0.81 PDE7A (0.39) TSHRCYP3A4ALDH1A1KMT2AMEN1
SCHEMBL11413362 0.81 TSHR (0.53) TSHRCYP3A4ALDH1A1KMT2AMEN1
SCHEMBL2847249 0.81 PDE7A (0.57) TSHRALDH1A1KMT2AMAPTTDP1
SCHEMBL2593514 0.80 PDE7A (0.51) ALDH1A1KMT2AMEN1MAPTHSD17B10
SCHEMBL30886771 0.80 PDE7A (0.51) ALDH1A1KMT2AMEN1MAPTHSD17B10
SCHEMBL14866257 0.79 MAPT (0.48) CYP3A4ALDH1A1KMT2AMEN1MAPT
SCHEMBL1340033 0.79 TSHR (0.51) TSHRCYP3A4ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 TSHR 3964/4885CYP3A4 3570/4885ALDH1A1 1554/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 TSHR 3964/4885CYP3A4 3570/4885ALDH1A1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.